1,923 results on '"Ten Cate, Hugo"'
Search Results
2. Association between coagulation activity and clinical and imaging outcomes in acute ischemic stroke patients - A sub-study of the MR CLEAN NO-IV trial
3. Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry
4. NETosis in Cardiovascular Disease: An Opportunity for Personalized Antithrombotic Treatments?
5. The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization
6. Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands
7. Deferring diagnostic evaluation of suspected deep vein thrombosis using direct oral anticoagulant or low-molecular-weight heparin as a single dose anticoagulant: A prospective real-world study in a regionwide care pathway
8. Altered whole blood thrombin generation and hyperresponsive platelets in patients with pancreatic cancer
9. Current and potentially novel antithrombotic treatment in acute ischemic stroke
10. Heparins, fondaparinux, hirudin, bivalirudin, argatroban, and danaparoid
11. The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-associated vasculitis
12. Anticoagulation in cancer patients with atrial fibrillation and grade 3–4 thrombocytopenia
13. Chronic inflammatory diseases increase the risk of post-thrombotic syndrome: A prospective cohort study
14. Rotational thromboelastometry as a biomarker for mortality — The Maastricht Intensive Care COVID cohort
15. Budget Impact of Three Improvement Targets for Compression Therapy for Patients with Deep Venous Thrombosis in The Netherlands
16. Outcomes of Oral Anticoagulation in Atrial Fibrillation Patients With or Without Comorbid Vascular Disease: Insights From the GARFIELD-AF Registry
17. Crucial roles of red blood cells and platelets in whole blood thrombin generation
18. Applications of rotational thromboelastometry in heparin monitoring in critical COVID-19 disease: Observations in the Maastricht Intensive Care COVID cohort
19. Pulmonary embolism in hospitalized COVID-19 patients: Short- and long-term clinical outcomes
20. Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis
21. Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification
22. Predictive value for increased activated factor XI activity in acute venous thromboembolism
23. Coagulation biomarkers for ischemic stroke
24. Exploring phenotypes of deep vein thrombosis in relation to clinical outcomes beyond recurrence
25. Repeated platelet activation and the potential of previously activated platelets to contribute to thrombus formation
26. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
27. Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism
28. Lower levels of vWF are associated with lower risk of cardiovascular disease
29. Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis
30. Clinical impact of assessing thrombus age using magnetic resonance venography prior to catheter-directed thrombolysis
31. Hemostatic biomarkers and antithrombotic strategy in percutaneous left atrial interventions: State-of-the-art review
32. The wonders of anticoagulation.
33. Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle.
34. Factor XI inhibitors in patients with cardiovascular disease and a high risk of bleeding: a cautionary tale
35. Evolving data on cardiovascular complications in cancer
36. Variation of platelet function in clinical phenotypes of acute venous thromboembolism – Results from the GMP‐VTE project
37. Thrombin generation by calibrated automated thrombography in goat plasma: Optimization of an assay
38. Systematic review and meta-analysis of the clinical effectiveness of point-of-care testing for anticoagulation management during ECMO
39. Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis
40. Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background
41. Activated factor XI-antithrombin complex presenting as an independent predictor of 30-days mortality in out-of-hospital cardiac arrest patients
42. Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
43. Thrombin generation is associated with ischemic stroke at a young age
44. Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability
45. Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: A systematic review
46. Caging the dragon: Research approach to COVID‐19–related thrombosis
47. Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy
48. Interpreting high levels of unfolded Von Willebrand Factor in patients with the antiphospholipid syndrome.
49. Design-related bias in studies investigating diagnostic tests for venous thromboembolic diseases: a systematic review and meta-analysis.
50. Comparative Analysis of Coagulation Activation in Rheumatoid Arthritis Patients Treated With TNF Inhibitors Versus JAK Inhibitors: A Longitudinal Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.